Colorcon, Inc. Invests in a New Film Coating Manufacturing Plant in Malaysia
Comunicato Precedente
Comunicato Successivo
According to CPHI's 2022 Global Survey, the ASEAN pharmaceutical manufacturing industry will grow by 12.8% annually over 2021-2027 driven by increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure.
Simon Tasker, CEO, Colorcon Inc. explains: "This investment strengthens our strategy to position Colorcon facilities close to our customers and support the projected growth in the region. The new plant in Malaysia will reduce delivery lead-times, improve our sustainability and strengthen our assurance of supply for our customers in the region; while assuring quality and equivalency of product manufactured at any of our network of manufacturing locations around the world."
Willem Hoogwater, Managing Director – NESEA explains: "We want to make it easy for customers to work with Colorcon. The new plant represents a significant commitment to customer satisfaction, convenience, and the resilience of the supply chain in Southeast Asia. The investment in regional production will further enhance Colorcon's ability to provide the high service level our customers expect, and we believe our customers deserve."
This investment in local manufacturing will improve Colorcon's flexibility in the scheduling of production, resulting in higher efficiency for customers and secure the supply chain to meet future industry needs. Colorcon has 11 manufacturing facilities, 25 technical service laboratories globally and more than 1400 employees exclusively dedicated to its customer base.
For more information, visit www.colorcon.com.
Photo - https://mma.prnewswire.com/media/2092957/Colorcon_Inc.jpg
Logo - https://mma.prnewswire.com/media/2013712/4069588/Colorcon_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/colorcon-inc-invests-in-a-new-film-coating-manufacturing-plant-in-malaysia-301842657.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
